---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-304033"
form_type: "8-K"
ticker: "MD"
cik: "0000893949"
company_name: "Pediatrix Medical Group, Inc."
filed_at: "2026-07-15T11:00:15+00:00"
generated_at: "2026-07-15T11:05:05.781975+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Pediatrix reaffirms FY 2026 Adjusted EBITDA guidance of $280M-$300M; payor mix stable

## Summary
- Payor mix for Q2 2026 remained stable and unchanged relative to recent historical trends and internal expectations.
- Company has not experienced unfavorable payor mix shifts reported elsewhere in healthcare sector.
- Reaffirms full year 2026 Adjusted EBITDA outlook in range of $280 million to $300 million.
- No material changes in other net revenue-related trends compared to recent historical periods.
- Earnings conference call scheduled for August 4, 2026 at 9:00 a.m. ET to discuss Q2 results.

## SEC filing metadata
- accession: 0001193125-26-304033
- form_type: 8-K
- ticker: MD
- cik: 0000893949
- company_name: Pediatrix Medical Group, Inc.
- filed_at: 2026-07-15T11:00:15+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/893949/000119312526304033/0001193125-26-304033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/893949/000119312526304033/md-20260715.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-304033
- JSON: https://secwatch.observer/filing/0001193125-26-304033.json
- Plain text: https://secwatch.observer/filing/0001193125-26-304033.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.